ATE437241T1 - Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittels - Google Patents
Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittelsInfo
- Publication number
- ATE437241T1 ATE437241T1 AT07120168T AT07120168T ATE437241T1 AT E437241 T1 ATE437241 T1 AT E437241T1 AT 07120168 T AT07120168 T AT 07120168T AT 07120168 T AT07120168 T AT 07120168T AT E437241 T1 ATE437241 T1 AT E437241T1
- Authority
- AT
- Austria
- Prior art keywords
- anticancer agent
- determining
- anthracycline anticancer
- susceptibility
- effectiveness
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/44—Multiple drug resistance
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006307276A JP4795203B2 (ja) | 2006-11-13 | 2006-11-13 | アンスラサイクリン系抗癌剤の感受性判定方法及びそのシステム |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE437241T1 true ATE437241T1 (de) | 2009-08-15 |
Family
ID=38969820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07120168T ATE437241T1 (de) | 2006-11-13 | 2007-11-07 | Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittels |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7718393B2 (de) |
| EP (1) | EP1921170B1 (de) |
| JP (1) | JP4795203B2 (de) |
| AT (1) | ATE437241T1 (de) |
| DE (1) | DE602007001656D1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12366585B2 (en) | 2006-05-18 | 2025-07-22 | Caris Mpi, Inc. | Molecular profiling of tumors |
| IL313131A (en) * | 2009-02-11 | 2024-07-01 | Caris Mpi Inc | Molecular characterization of tumors |
| EP2432872B1 (de) * | 2009-05-22 | 2015-09-30 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Akt-phosphorylierung an ser473 als indikator für chemotherapie auf der basis von taxan |
| JP5830249B2 (ja) * | 2010-03-31 | 2015-12-09 | シスメックス株式会社 | 癌細胞のアンスラサイクリン系抗癌剤への感受性の判定方法及びコンピュータプログラム |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4317913B2 (ja) * | 2000-04-14 | 2009-08-19 | ベンタナ・メデイカル・システムズ・インコーポレーテツド | Aktタンパク質発現の定量方法 |
| AU2003291736A1 (en) * | 2002-11-05 | 2004-06-03 | Cell Signaling Technology, Inc. | Methods and materials for examining pathways associated with glioblastoma progression |
| WO2004053497A2 (en) * | 2002-12-11 | 2004-06-24 | Ventana Medical Systems, Inc. | Method for predicting the response to her2-directed therapy |
| EP1599573B1 (de) * | 2003-02-17 | 2013-06-19 | Cold Spring Harbor Laboratory | Modell zur untersuchung der rolle von genen bei tumorresistenz in der chemotherapie |
| JP2004357552A (ja) * | 2003-06-03 | 2004-12-24 | Hitachi Ltd | 作用物質による効果推定方法及びスクリーニング方法 |
| EP2439284B1 (de) * | 2004-03-31 | 2019-05-08 | The General Hospital Corporation | Verfahren zur Bestimmung des Ansprechens von Krebs auf den epidermalen Wachstumsfaktorrezeptor gerichtete Behandlungen |
| JPWO2006082866A1 (ja) * | 2005-02-01 | 2008-06-26 | 萬有製薬株式会社 | p53の機能異常の検出方法、癌の分子診断方法及び癌治療に有効な化合物の評価方法 |
| AR053272A1 (es) * | 2005-05-11 | 2007-04-25 | Hoffmann La Roche | Determinacion de responsivos a la quimioterapia |
-
2006
- 2006-11-13 JP JP2006307276A patent/JP4795203B2/ja not_active Expired - Fee Related
-
2007
- 2007-11-07 AT AT07120168T patent/ATE437241T1/de not_active IP Right Cessation
- 2007-11-07 EP EP20070120168 patent/EP1921170B1/de not_active Not-in-force
- 2007-11-07 DE DE200760001656 patent/DE602007001656D1/de active Active
- 2007-11-13 US US11/939,138 patent/US7718393B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1921170A3 (de) | 2008-06-04 |
| US20080124750A1 (en) | 2008-05-29 |
| EP1921170A2 (de) | 2008-05-14 |
| JP4795203B2 (ja) | 2011-10-19 |
| US7718393B2 (en) | 2010-05-18 |
| DE602007001656D1 (de) | 2009-09-03 |
| EP1921170B1 (de) | 2009-07-22 |
| JP2008122258A (ja) | 2008-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008073899A3 (en) | Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis | |
| EP1849001A4 (de) | Seitenstrom-testsatz und verfahren zum nachweis eines analyten | |
| EP2186238A4 (de) | Vorrichtung und verfahren zum durchführen von sicheren finanztransaktionen | |
| EP2056715A4 (de) | Funktionelle untersuchungs- und behandlungskatheter sowie verfahren zu ihrer verwendung in der lunge | |
| WO2009085234A3 (en) | Use of micro-rna as a biomarker of immunomodulatory drug activity | |
| EP2203209A4 (de) | Kathetergerät und verfahren zur behandlung von gefässen | |
| EP2187829A4 (de) | System und verfahren zur messung einer impedanz mittels eines katheters, z.b. eines ablationskatheters | |
| EP2209495A4 (de) | Taz/wwtr1 zur diagnose und behandlung von krebs | |
| WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
| WO2008095492A3 (en) | A method for diagnosing atherosclerotic plaques by measurement of cd36 | |
| WO2013063155A3 (en) | Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof | |
| DE112007003573A5 (de) | Verfahren zum Bestimmen eines eine Erdimpedanz angebenden Einstellwertes und Messeinrichtung | |
| EP2118654A4 (de) | Diagnostischer test zum nachweis eines moleküls oder arzneistoffs in vollblut | |
| CY1115439T1 (el) | Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου | |
| EP4218570A3 (de) | Polymermembranen für kontinuierliche analytsensoren | |
| EP1983889A4 (de) | Verfahren und vorrichtung zum testen von blutgerinnung | |
| BR112012002594A2 (pt) | dispositivo e método para detectar sangue ou constituintes de sangue no sistema de líquido de um dispositivo para tratamento de sangue extracorpóreo | |
| DE112007000332A5 (de) | Vorrichtung und Verfahren zum Bestimmen eines Freiraums vor einem Fahrzeug | |
| EP4183338A4 (de) | Vorrichtung zum nachweis von analyten in körperflüssigkeiten | |
| EP2164990A4 (de) | Zusammensetzungen, kits und verfahren zur identifizierung, beurteilung, vorbeugung und therapie von krebs | |
| DE602007001656D1 (de) | Verfahren zum Ermitteln der Wirksamkeit eines Anthracyclin-Antikrebsmittels | |
| DE602006009890D1 (de) | Verfahren zum Hinzufügen eines Effekts und Vorrichtung zum Hinzufügen eines Effekts | |
| DE502007004852D1 (de) | Vorrichtung mit fluidverteiler und messwerterfassung sowie verfahren zum betrieb eines mit rauchgas durchströmten kessels | |
| WO2009022988A3 (en) | Vhz for diagnosis and treatment of cancer | |
| SG179070A1 (en) | Method to identify a patient with an increased likelihood of responding to an anti-cancer agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |